The real-world efficacy and safety of frontline therapy of obinutuzumab plus bendamustine for untreated high-tumor-burden follicular lymphoma. - Nagata, Hiroaki; Tsukamoto, Taku; Kobayashi, Tsutomu; Takahashi, Ryoichi; Okano, Akira; Uchiyama, Hitoji; Kawata, Eri; Uoshima, Nobuhiko; Kaneko, Hiroto; Fuchida, Shin-ichi; Nishiyama, Daichi; Nakao, Mitsushige; et al. (International Journal of Clinical Oncology, 2025)